PTC
IMVT icon

Private Trust Company’s Immunovant IMVT Stock Holding History

Private Trust Company’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-112
Closed -$2.96K – 2323
2024
Q2 		$2.96K Hold
112
– – ﹤0.01% 2082
2024
Q1 		$3.62K Sell
112
-81
-42% -$2.96K ﹤0.01% 2011
2023
Q4 		$8.13K Buy
193
+53
+38% +$1.95K ﹤0.01% 1728
2023
Q3 		$5.38K Buy
+140
New +$3.17K ﹤0.01% 1843

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Private Trust Company's IMVT Position: Q3 2024 in Review

Private Trust Company sold out of Immunovant (IMVT) in Q3 2024, closing a stake of 112 shares — an estimated $2.96K sold.

Private Trust Company first reported a position in IMVT in Q3 2023 and held it in 4 quarters. The position peaked at $8.13K in Q4 2023. 181 funds tracked by Wall St. Rank hold IMVT as of Q3 2024.

  • Private Trust Company reported no remaining Immunovant position as of Q3 2024 after selling out during the quarter.
  • Private Trust Company sold 112 Immunovant shares in Q3 2024, an estimated $2.96K.
  • Private Trust Company first reported a position in Immunovant in Q3 2023 and held it in 4 quarters.
  • Private Trust Company's Immunovant position peaked at $8.13K in Q4 2023.
  • 181 funds tracked by Wall St. Rank held Immunovant as of Q3 2024.

Based on Private Trust Company's 13F filing for Q3 2024, filed 13 Nov 2024.